Lennar Corporation
Lennar Corporation (LEN-B) Stock Competitors & Peer Comparison
See (LEN-B) competitors and their performances in Stock Market.
Peer Comparison Table: Residential Construction Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| LEN-B | $110.83 | +1.88% | 29.7B | 9.18 | $12.07 | +1.73% |
| DHI | $145.32 | +0.43% | 44.6B | 11.67 | $12.45 | +1.03% |
| LEN | $115.33 | +1.60% | 29.7B | 9.56 | $12.07 | +1.73% |
| PHM | $116.35 | +0.28% | 23B | 8.71 | $13.36 | +0.74% |
| NVR | $7,792.93 | +0.05% | 22.8B | 16.48 | $472.82 | N/A |
| TOL | $123.04 | +0.34% | 12.1B | 9.15 | $13.45 | +0.78% |
| TMHC | $60.75 | +0.05% | 6B | 7.03 | $8.65 | N/A |
| MTH | $69.77 | -1.80% | 5B | 7.96 | $8.77 | +2.30% |
| MDC | $62.98 | +0.05% | 4.7B | 11.91 | $5.29 | N/A |
| KBH | $56.86 | +0.55% | 3.9B | 7.54 | $7.54 | +1.77% |
Stock Comparison
LEN-B vs DHI Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, DHI has a market cap of 44.6B. Regarding current trading prices, LEN-B is priced at $110.83, while DHI trades at $145.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas DHI's P/E ratio is 11.67. In terms of profitability, LEN-B's ROE is +0.16%, compared to DHI's ROE of +0.16%. Regarding short-term risk, LEN-B is more volatile compared to DHI. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check DHI's competition here
LEN-B vs LEN Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, LEN has a market cap of 29.7B. Regarding current trading prices, LEN-B is priced at $110.83, while LEN trades at $115.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas LEN's P/E ratio is 9.56. In terms of profitability, LEN-B's ROE is +0.16%, compared to LEN's ROE of +0.16%. Regarding short-term risk, LEN-B is more volatile compared to LEN. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LEN's competition here
LEN-B vs PHM Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, PHM has a market cap of 23B. Regarding current trading prices, LEN-B is priced at $110.83, while PHM trades at $116.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas PHM's P/E ratio is 8.71. In terms of profitability, LEN-B's ROE is +0.16%, compared to PHM's ROE of +0.18%. Regarding short-term risk, LEN-B is more volatile compared to PHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check PHM's competition here
LEN-B vs NVR Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, NVR has a market cap of 22.8B. Regarding current trading prices, LEN-B is priced at $110.83, while NVR trades at $7,792.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas NVR's P/E ratio is 16.48. In terms of profitability, LEN-B's ROE is +0.16%, compared to NVR's ROE of +0.48%. Regarding short-term risk, LEN-B is more volatile compared to NVR. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NVR's competition here
LEN-B vs TOL Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, TOL has a market cap of 12.1B. Regarding current trading prices, LEN-B is priced at $110.83, while TOL trades at $123.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas TOL's P/E ratio is 9.15. In terms of profitability, LEN-B's ROE is +0.16%, compared to TOL's ROE of +0.18%. Regarding short-term risk, LEN-B is more volatile compared to TOL. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TOL's competition here
LEN-B vs TMHC Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, TMHC has a market cap of 6B. Regarding current trading prices, LEN-B is priced at $110.83, while TMHC trades at $60.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas TMHC's P/E ratio is 7.03. In terms of profitability, LEN-B's ROE is +0.16%, compared to TMHC's ROE of +0.15%. Regarding short-term risk, LEN-B is less volatile compared to TMHC. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check TMHC's competition here
LEN-B vs MTH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, MTH has a market cap of 5B. Regarding current trading prices, LEN-B is priced at $110.83, while MTH trades at $69.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas MTH's P/E ratio is 7.96. In terms of profitability, LEN-B's ROE is +0.16%, compared to MTH's ROE of +0.16%. Regarding short-term risk, LEN-B is less volatile compared to MTH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check MTH's competition here
LEN-B vs MDC Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, MDC has a market cap of 4.7B. Regarding current trading prices, LEN-B is priced at $110.83, while MDC trades at $62.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas MDC's P/E ratio is 11.91. In terms of profitability, LEN-B's ROE is +0.16%, compared to MDC's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to MDC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MDC's competition here
LEN-B vs KBH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, KBH has a market cap of 3.9B. Regarding current trading prices, LEN-B is priced at $110.83, while KBH trades at $56.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas KBH's P/E ratio is 7.54. In terms of profitability, LEN-B's ROE is +0.16%, compared to KBH's ROE of +0.14%. Regarding short-term risk, LEN-B is more volatile compared to KBH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check KBH's competition here
LEN-B vs SKY Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, SKY has a market cap of 3.7B. Regarding current trading prices, LEN-B is priced at $110.83, while SKY trades at $65.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas SKY's P/E ratio is 19.03. In terms of profitability, LEN-B's ROE is +0.16%, compared to SKY's ROE of +0.13%. Regarding short-term risk, LEN-B is more volatile compared to SKY. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SKY's competition here
LEN-B vs CVCO Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, CVCO has a market cap of 3.4B. Regarding current trading prices, LEN-B is priced at $110.83, while CVCO trades at $417.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas CVCO's P/E ratio is 20.14. In terms of profitability, LEN-B's ROE is +0.16%, compared to CVCO's ROE of +0.17%. Regarding short-term risk, LEN-B is more volatile compared to CVCO. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check CVCO's competition here
LEN-B vs MHO Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, MHO has a market cap of 3.3B. Regarding current trading prices, LEN-B is priced at $110.83, while MHO trades at $122.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas MHO's P/E ratio is 6.71. In terms of profitability, LEN-B's ROE is +0.16%, compared to MHO's ROE of +0.15%. Regarding short-term risk, LEN-B is more volatile compared to MHO. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check MHO's competition here
LEN-B vs GRBK Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, GRBK has a market cap of 2.9B. Regarding current trading prices, LEN-B is priced at $110.83, while GRBK trades at $66.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas GRBK's P/E ratio is 7.97. In terms of profitability, LEN-B's ROE is +0.16%, compared to GRBK's ROE of +0.24%. Regarding short-term risk, LEN-B is more volatile compared to GRBK. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check GRBK's competition here
LEN-B vs TPH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, TPH has a market cap of 2.9B. Regarding current trading prices, LEN-B is priced at $110.83, while TPH trades at $31.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas TPH's P/E ratio is 8.04. In terms of profitability, LEN-B's ROE is +0.16%, compared to TPH's ROE of +0.11%. Regarding short-term risk, LEN-B is more volatile compared to TPH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check TPH's competition here
LEN-B vs DFH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, DFH has a market cap of 2.6B. Regarding current trading prices, LEN-B is priced at $110.83, while DFH trades at $27.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas DFH's P/E ratio is 8.26. In terms of profitability, LEN-B's ROE is +0.16%, compared to DFH's ROE of +0.25%. Regarding short-term risk, LEN-B is less volatile compared to DFH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check DFH's competition here
LEN-B vs CCS Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, CCS has a market cap of 1.8B. Regarding current trading prices, LEN-B is priced at $110.83, while CCS trades at $59.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas CCS's P/E ratio is 7.27. In terms of profitability, LEN-B's ROE is +0.16%, compared to CCS's ROE of +0.10%. Regarding short-term risk, LEN-B is less volatile compared to CCS. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check CCS's competition here
LEN-B vs LGIH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, LGIH has a market cap of 1.3B. Regarding current trading prices, LEN-B is priced at $110.83, while LGIH trades at $57.58.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas LGIH's P/E ratio is 7.43. In terms of profitability, LEN-B's ROE is +0.16%, compared to LGIH's ROE of +0.09%. Regarding short-term risk, LEN-B is less volatile compared to LGIH. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check LGIH's competition here
LEN-B vs GRBK-PA Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, GRBK-PA has a market cap of 1.1B. Regarding current trading prices, LEN-B is priced at $110.83, while GRBK-PA trades at $24.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas GRBK-PA's P/E ratio is 5.48. In terms of profitability, LEN-B's ROE is +0.16%, compared to GRBK-PA's ROE of +0.24%. Regarding short-term risk, LEN-B is more volatile compared to GRBK-PA. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check GRBK-PA's competition here
LEN-B vs BZH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, BZH has a market cap of 746.4M. Regarding current trading prices, LEN-B is priced at $110.83, while BZH trades at $24.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas BZH's P/E ratio is 7.97. In terms of profitability, LEN-B's ROE is +0.16%, compared to BZH's ROE of +0.08%. Regarding short-term risk, LEN-B is more volatile compared to BZH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check BZH's competition here
LEN-B vs HOVNP Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, HOVNP has a market cap of 700.4M. Regarding current trading prices, LEN-B is priced at $110.83, while HOVNP trades at $19.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas HOVNP's P/E ratio is -7.77. In terms of profitability, LEN-B's ROE is +0.16%, compared to HOVNP's ROE of +0.27%. Regarding short-term risk, LEN-B is more volatile compared to HOVNP. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check HOVNP's competition here
LEN-B vs HOV Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, HOV has a market cap of 607.4M. Regarding current trading prices, LEN-B is priced at $110.83, while HOV trades at $120.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas HOV's P/E ratio is 4.24. In terms of profitability, LEN-B's ROE is +0.16%, compared to HOV's ROE of +0.27%. Regarding short-term risk, LEN-B is less volatile compared to HOV. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check HOV's competition here
LEN-B vs LEGH Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, LEGH has a market cap of 548.7M. Regarding current trading prices, LEN-B is priced at $110.83, while LEGH trades at $22.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas LEGH's P/E ratio is 9.93. In terms of profitability, LEN-B's ROE is +0.16%, compared to LEGH's ROE of +0.12%. Regarding short-term risk, LEN-B is more volatile compared to LEGH. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check LEGH's competition here
LEN-B vs SIC Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, SIC has a market cap of 376M. Regarding current trading prices, LEN-B is priced at $110.83, while SIC trades at $14.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas SIC's P/E ratio is 7.11. In terms of profitability, LEN-B's ROE is +0.16%, compared to SIC's ROE of -0.06%. Regarding short-term risk, LEN-B is more volatile compared to SIC. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check SIC's competition here
LEN-B vs UHG Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, UHG has a market cap of 244M. Regarding current trading prices, LEN-B is priced at $110.83, while UHG trades at $4.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas UHG's P/E ratio is 5.57. In terms of profitability, LEN-B's ROE is +0.16%, compared to UHG's ROE of +0.80%. Regarding short-term risk, LEN-B is less volatile compared to UHG. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check UHG's competition here
LEN-B vs SPHL Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, SPHL has a market cap of 5.9M. Regarding current trading prices, LEN-B is priced at $110.83, while SPHL trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas SPHL's P/E ratio is -12.83. In terms of profitability, LEN-B's ROE is +0.16%, compared to SPHL's ROE of -0.18%. Regarding short-term risk, LEN-B is less volatile compared to SPHL. This indicates potentially lower risk in terms of short-term price fluctuations for LEN-B.Check SPHL's competition here
LEN-B vs NWHM Comparison July 2025
LEN-B plays a significant role within the Consumer Cyclical sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, LEN-B stands at 29.7B. In comparison, NWHM has a market cap of 0. Regarding current trading prices, LEN-B is priced at $110.83, while NWHM trades at $8.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
LEN-B currently has a P/E ratio of 9.18, whereas NWHM's P/E ratio is N/A. In terms of profitability, LEN-B's ROE is +0.16%, compared to NWHM's ROE of -0.15%. Regarding short-term risk, LEN-B is more volatile compared to NWHM. This indicates potentially higher risk in terms of short-term price fluctuations for LEN-B.Check NWHM's competition here